The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Americhem Europe Limited is a private company limited by shares incorporated in England and Wales. The registered office is 3 Bunhill Row, London, EC1Y 8YZ.

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

The company ceased trading in February 2022. It is the intention of the directors that the company will be wound up when the company will have met its operating lease commitments in September 2025 and the intercompany balances cleared. Notwithstanding this, there are no material changes in the carrying values of the assets and liabilities as a result of this decision. Accordingly the financial statements have been prepared on a basis other than going concern. true

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities, including creditors and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

Provisions are recognised when the company has a legal or constructive present obligation as a result of a past event, it is probable that the company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the reporting end date, taking into account the risks and uncertainties surrounding the obligation. Where the effect of the time value of money is material, the amount expected to be required to settle the obligation is recognised at present value. When a provision is measured at present value, the unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leases asset are consumed.

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

The estimations and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows:

The closure provision has been recognised as a result of the director’s decision to transition its UK warehouse operations to a different Americhem Inc. entity. The company made their final sales and factory ceased production in February 2022. The provision recognised is a present obligation as a result of a past event, where reliable estimates have been made on the outflow of resources embodying economic benefits. The provision includes the amortised rentals and rates expenditure associated with the onerous lease, amounting to £228,797. Dilapidation costs have been negotiated and a maximum payment in lieu of all dilapidation liabilities has been agreed at £105,000, which has been included in the provision. Severance costs of £30,000 continue to be recognised and will be settled post year end on conclusion of employment contracts. These costs are based on actual spend post year end and estimated costs that are to be incurred until the full closure of the business. The provision is reviewed by management on a regular basis. The directors are comfortable with the provision recognised to date, based on actual and estimated costs. The total closure provision as at the year end amounts to £388,518 (2023: £716,703).

The average monthly number of persons (including directors) employed by the company during the year was:

The Ordinary A & B shares rank pari pasu.

The Redeemable preference shares do not confer any right on redemption, and do not have any right to vote or right to a dividend.

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006:

The auditor's report was unqualified.

Emphasis of matter - financial statements prepared on a basis other than going concern

As stated in note 1.2 the company ceased trading in February 2022. It is the intention of the directors that the company will be wound up when the company will have met its operating lease commitments in September 2025 and the intercompany balances cleared. Accordingly the financial statements have been prepared on a basis other than going concern.

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

The immediate parent company is Americhem Holdings International Limited, a company incorporated in England & Wales. The ultimate parent company is Americhem Inc, a company incorporated in the United States of America.

The smallest group in which the results of the company are consolidated is that headed by Americhem Holdings International Limited.

The largest group in which the results of the company are consolidated is that headed by Americhem Inc.

The group accounts of Americhem Holdings Limited are available to the public and can be obtained from 3 Bunhill Row, London, EC1Y 8YZ.